The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Evaluating clinical responses to BRAF inhibition in BRAF/TERT promoter mutated melanoma.
 
Colleen Ciccosanti
No Relationships to Disclose
 
Alexander Hershey
No Relationships to Disclose
 
Chunxia Chen
No Relationships to Disclose
 
Dirk F. Moore
No Relationships to Disclose
 
Ryan D. Stephenson
No Relationships to Disclose
 
Joseph P. Weiner
No Relationships to Disclose
 
Vadim P. Koshenkov
No Relationships to Disclose
 
Ann W. Silk
Consulting or Advisory Role - Bristol-Myers Squibb; EMD Serono; Merck
Research Funding - Amgen (Inst); Biohaven Pharmaceuticals (Inst); Bristol-Myers Squibb (Inst); Merck (Inst); Prometheus (Inst); Viralytics (Inst)
 
Janice M. Mehnert
Stock and Other Ownership Interests - Pfizer
Honoraria - EMD Serono; Pfizer/EMD Serono
Consulting or Advisory Role - Bristol-Myers Squibb; Merck Sharp & Dohme; Sanofi/Regeneron; Sanofi/Regeneron; Seagen
Research Funding - Amgen (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Incyte (Inst); macrogenics (Inst); macrogenics (Inst); Merck (Inst); Novartis (Inst); Regeneron (Inst)
Travel, Accommodations, Expenses - Array BioPharma; Bristol-Myers Squibb; EMD Serono; Merck Sharp & Dohme
 
Adam C. Berger
Honoraria - Cardinal Health
Consulting or Advisory Role - Cardinal Health
 
Roman Groisberg
Honoraria - Regeneron
Speakers' Bureau - Rockpointe CME; TotalCME